(Q28290548)

English

Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study

scientific article published on January 1, 1995

In more languages

Statements

scholarly article

0 references

Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study (English)

0 references

0 references

author name string

Y. Goto

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7579007

20 May 2024

N. Hotta

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7579007

20 May 2024

Y. Shigeta

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7579007

20 May 2024

N. Sakamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7579007

20 May 2024

R. Kikkawa

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7579007

20 May 2024

language of work or name

0 references

publication date

1995

0 references

full work available at URL

https://api.elsevier.com/content/article/PII:0753332296826424?httpAccept=text/xml

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

https://api.elsevier.com/content/article/PII:0753332296826424?httpAccept=text/plain

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Biomedicine and Pharmacotherapy

1 reference

49

0 references

6

0 references

269-77

0 references

The sorbitol pathway and the complications of diabetes

1

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy

2

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Effect of blood sugar control on the accumulation of sorbitol and fructose in nervous tissues

5

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function

7

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

8

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

A placebo-controlled double-blind study of epalrestat (ONO-2235) in patients with diabetic neuropathy

9

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition

10

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Effects of a new aldose reductase inhibitor on various tissues in vitro

12

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Prevention of peripheral nerve dysfunction by an aldose reductase inhibitor in streptozotocin-diabetic rats

13

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats

15

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

16

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Plasma and red cell sorbitol assay in diabetic subjects.

21

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy

22

1 reference

10.1016/0753-3322(96)82642-4

https://api.crossref.org/works/10.1016/0753-3322(96)82642-4

20 May 2024

Identifiers

10.1016/0753-3322(96)82642-4

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28290548&oldid=2160033437"